Kate Rainczuk Selected Research

AZ 11645373

10/2019

Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kate Rainczuk Research Topics

Disease

3	Endometrial Neoplasms (Endometrial Cancer) 07/2016 - 01/2016
3	Neoplasms (Cancer) 07/2016 - 01/2016
1	Albuminuria 10/2020
1	Infections 10/2019
1	Inflammation (Inflammations) 10/2019
1	Human Influenza (Influenza) 10/2019
1	Infertility (Sterility) 01/2019
1	Carcinogenesis 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 10/2019 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 07/2016 - 01/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	Type 1 Angiotensin ReceptorIBA 10/2020
1	Interleukin-10 (Interleukin 10)IBA 10/2020
1	ReninIBA 10/2020
1	AngiotensinogenIBA 10/2020
1	AZ 11645373IBA 10/2019
1	Purinergic P2X7 ReceptorsIBA 10/2019
1	InflammasomesIBA 10/2019
1	Probenecid (Benemid)FDA LinkGeneric 10/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 07/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Interleukin-11 (Interleukin 11)IBA 01/2016
1	Interleukin-11 Receptors (Interleukin 11 Receptor)IBA 01/2016
1	flotillinsIBA 01/2016